Trial Profile

Phase 2 trial of AKB-9778 topical formulation in open angle glaucoma

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 13 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Razuprotafib (Primary)
Indications Open-angle glaucoma
Focus Therapeutic Use
Sponsors Aadi Bioscience; Aerpio Pharmaceuticals

Most Recent Events

18 Mar 2020 New trial record
16 Mar 2020 According to an Aerpio media release, trial is expected to initiate in the third quarter of this year. Once initiated, topline results from this trial to read out in the first quarter of 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com